BASSO, MONICA
BASSO, MONICA
Dipartimento di Medicina Molecolare - DMM
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement].
2004 Sulli, A; Burroni, A; Tuccio, M; Pizzorni, C; Craviotto, C; Ghio, M; Basso, Monica; Seriolo, B; Cutolo, M.
A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit
2019 Basso, M.; Venditti, C.; Raponi, G.; Navazio, A. S.; Alessandri, F.; Giombini, E.; Nisii, C.; Di Caro, A.; Venditti, M.
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
2006 Ciancio, A; Picciotto, A; Giordanino, C; Smedile, A; Tabone, M; Manca, A; Marenco, G; Garbagnoli, P; Andreoni, M; Cariti, G; Calleri, G; Sartori, M; Cusumano, S; Grasso, A; Rizzi, R; Gallo, M; Basso, Monica; Anselmo, M; Percario, G; Ciccone, G; Rizzetto, M; Saracco, G.
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy.
2009 Giannini, Eg; Torre, F; Basso, Monica; Feasi, M; Boni, S; Grasso, A; De Leo, P; Dodi, F; Marazzi, Mg; Azzola, E; Bartolacci, V; Percario, G; Beltrame, A; Borro, P; Savarino, V; Picciotto, A; Ligurian Hepatitis B., Virus Study Group
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects
2013 Parisi, Saverio; Samantha, Andreis; Carlo, Mengoli; Renzo, Scaggiante; Mario, Cruciani; Roberto, Ferretto; Vinicio, Manfrin; Sandro, Panese; Basso, Monica; Caterina, Boldrin; Stefania, Bressan; Loredana, Sarmati; Massimo, Andreoni; Palu', Giorgio
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin
2014 Santantonio, Teresa; Fasano, Massimo; Sagnelli, Evangelista; Tundo, Paolo; Babudieri, Sergio; Fabris, Paolo; Toti, Mario; Di Perri, Giovanni; Marino, Nicoletta; Pizzigallo, Eligio; Angarano, Gioacchino; Pastore, Giuseppe; Guastadisegni, Angela; Volpe, Anna; Stano, Francesca; Tommasi, Donato; Maci, Annamaria; Resta, Francesco; Loperfido, Pietro; Esposito, Roberto; Borghi, Vanni; Fontana, Tommaso; Francavilla, Ruggiero; Mazzola, Michele; Pipoli, Antonella; Stanzione, Marinella; Amoroso, Pietro; Lettieri, Gennaro; Messina, Vincenzo; Antonucci, Giorgio; Rosati, Silvia; Giacometti, Andrea; Costa, Chiara; De Stefano, Carlo Biagio; Cariti, Giuseppe; Tositti, Giulia; Piera Riccardi, M.; Verucchi, Gabriella; Francisci, Daniela; Petrelli, Enzo; Stoppini, Laura; Raimondo, Giovanni; Squadrito, Giovanni; Caccamo, Gaia; Antonino, Picciotto; Basso, Monica; Lazzarin, Adriano; Morsica, Giulia; Mian, Peter; Pristerà, Raffael
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy.
2012 Parisi, Saverio; Andreis, S; Mengoli, C; Scaggiante, R; Ferretto, R; Manfrin, V; Cruciani, M; Giobbia, M; Boldrin, C; Basso, Monica; Andreoni, M; Palu', Giorgio; Sarmati, L.
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects
2021 Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio
Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment
2022 Zago, D.; Pozzetto, I.; Pacenti, M.; Brancaccio, G.; Ragolia, S.; Basso, M.; Parisi, S. G.
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
2009 Torre, F; Basso, Monica; Giannini, Eg; Feasi, M; Boni, S; Grasso, A; De Leo, P; Dodi, F; Marazzi, Mg; Azzola, E; Bartolacci, V; Percario, G; Beltrame, A; Borro, P; Picciotto, A; Ligurian HBV Study, Group
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
2022 Vicenti, I.; Basso, M.; Dragoni, F.; Gatti, F.; Scaggiante, R.; Fiaschi, L.; Parisi, S. G.; Zazzi, M.
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study
2018 Basso, Monica; Andreis, Samantha; Scaggiante, Renzo; Franchin, Elisa; Zago, Daniela; Biasolo, Maria Angela; Del Vecchio, Claudia; Mengoli, Carlo; Sarmati, Loredana; Andreoni, Massimo; Palù, Giorgio; Parisi, Saverio Giuseppe
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin
2016 Parisi, Saverio; Loregian, Arianna; Andreis, Samantha; Nannetti, Giulio; Cavinato, Silvia; Basso, Monica; Scaggiante, Renzo; DAL BELLO, Federico; Messa, Lorenzo; Cattelan, Anna Maria; Palu', Giorgio
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004–2012 in the Veneto Region, Italy
2013 Parisi, Saverio; Andreis, Samantha; Renzo, Scaggiante; Mario, Cruciani; Roberto, Ferretto; Vinicio, Manfrin; Sandro, Panese; Maria Cristina, Rossi; Ermenegildo, Francavilla; Caterina, Boldrin; Federico Dal, Bello; Basso, Monica; Carlo, Mengoli; Massimo, Andreoni; Palu', Giorgio
Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases
2019 Mcdermott, J.; Parisi, S. G.; Martini, I.; Boldrin, C.; Franchin, E.; Dal Bello, F.; Gianelli Castiglione, A.; Boeri, E.; Sampaolo, M.; Basso, M.; Menegazzi, P.; Tagliaferro, L.; Palù, G.; Varnier, O. E.
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma
2017 Nannetti, Giulio; Messa, Lorenzo; Celegato, Marta; Pagni, Silvana; Basso, Monica; Parisi, Saverio G.; Palu', Giorgio; Loregian, Arianna
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013â2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors
2017 Andreis, Samantha; Basso, Monica; Scaggiante, Renzo; Cruciani, Mario; Ferretto, Roberto; Manfrin, Vinicio; Panese, Sandro; Rossi, Maria Cristina; Francavilla, Ermenegildo; Boldrin, Caterina; Alvarez, Mario; DAL BELLO, Federico; Mengoli, Carlo; Turriziani, Ombretta; Sarmati, Loredana; Antonelli, Guido; Andreoni, Massimo; Palu', Giorgio; Parisi, Saverio
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
2009 Basso, Monica; Giannini, Eg; Torre, F; Blanchi, S; Savarino, V; Picciotto, A.
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men
2016 Scaggiante, Renzo; Andreis, Samantha; Basso, Monica; Franchin, Elisa; Franzetti, Marzia; DEL VECCHIO, Claudia; Torti, Carlo; Mengoli, Carlo; Cruciani, Mario; Sarmati, Loredana; Palu', Giorgio; Parisi, Saverio
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
2021 Vicenti, I.; Basso, M.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Modolo, E.; Dragoni, F.; Parisi, S. G.; Zazzi, M.